Our experience in the evaluation criteria used for the genetic study of patients suspected of being affected by multiple endocrine neoplasia type 1 and mutational spectrum

Gonzalez-Romero7, J. A. Garcia-Arnes7, A. Lecube8, J. Mesa9, R. Simo9, J. Rosell10, F. Sanchez-Garcia11, I. Recas12, F. Biarnes12, E. Pizarro13, I. Halperin1. 1 Bioquimica y Genetica Molecular, Endocrinologia, H. Clinic de Barcelona; 2 Cirugia, Endocrinologia, H. del Mar, Barcelona; 3 Endocrinologia, H. General Universitario Elda, Alicante; 4 Endocrinologia, H. de Bellvitge, Barcelona, 5Medicina Molecular, S. de Compostela; 6 Endocrinologia, H. Germans Trias Pujol, Badalona; 7Endocrinologia, H. Provincial de Malaga; 8H.Arnau de Vilanova, Lleida; 9H. Vall d’Hebron,Barcelona; 10Genetica, H.Son Espasses, P.Mallorca; 11Inmunologia, H.Dr. Negrin,Gran Canaria;12 Endocrinologia, H.J.Trueta, Girona; 13Endocrinologia, H.de Mataro. OUR EXPERIENCE IN THE EVALUATION CRITERIA USED FOR THE GENETIC STUDY OF PATIENTS SUSPECTED OF BEING AFFECTED BY MULTIPLE ENDOCRINE NEOPLASIA TYPE1 AND MUTATIONAL SPECTRUM